Sanctuary Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Buy
5,617
+445
+9% +$82K 0.01% 1319
2025
Q4
$910K Buy
5,172
+1,375
+36% +$225K 0.01% 1365
2025
Q3
$532K Buy
3,797
+616
+19% +$83.3K ﹤0.01% 1677
2025
Q2
$400K Buy
3,181
+942
+42% +$117K ﹤0.01% 1752
2025
Q1
$306K Buy
2,239
+116
+5% +$16.6K ﹤0.01% 1787
2024
Q4
$310K Sell
2,123
-1,842
-46% -$311K ﹤0.01% 1975
2024
Q3
$626K Sell
3,965
-2,016
-34% -$422K ﹤0.01% 1562
2024
Q2
$1.25M Buy
+5,981
New +$1.3M 0.01% 1074

Other funds holding BIIB

Sanctuary Advisors's BIIB Position: Q1 2026 in Review

Sanctuary Advisors increased its Biogen (BIIB) stake by 8.6% in Q1 2026, buying an estimated $82K and bringing the position to 5,617 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #1319.

Sanctuary Advisors first reported a position in BIIB in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.25M in Q2 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Sanctuary Advisors held 5,617 shares of Biogen worth $1.03M as of Q1 2026.
  • Sanctuary Advisors bought 445 Biogen shares in Q1 2026, an estimated $82K.
  • Biogen made up 0.01% of Sanctuary Advisors's portfolio in Q1 2026, its #1319 holding.
  • Sanctuary Advisors first reported a position in Biogen in Q2 2024 and has held it in 8 quarters since.
  • Sanctuary Advisors's Biogen position peaked at $1.25M in Q2 2024.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.